Form 4 holding
EVP, COO
Aptevo Therapeutics Inc.
- Security class
- Common Stock (post-reverse split May ACTIVE)
- Shares / value
- 6
- Estimated value
- $1
- Report date
- 17 Jul 2025
- Price
- $0.3000
- Ownership
- Direct
Jeffrey G. Lamothe - EVP, COO at Aptevo Therapeutics Inc.
Issuer-level insider activity
- Role
- Evp, Coo
- Issuer ticker
- APVO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jeffrey G. Lamothe since 09 Aug 2025
Reported holdings for Jeffrey G. Lamothe in Aptevo Therapeutics Inc.
Form 4 holding
EVP, COO
Aptevo Therapeutics Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 17,300
- Estimated value
- Report date
- 06 Aug 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jeffrey G. Lamothe in Aptevo Therapeutics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.